Dan Douer

11.5k total citations · 1 hit paper
192 papers, 5.7k citations indexed

About

Dan Douer is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Dan Douer has authored 192 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 77 papers in Public Health, Environmental and Occupational Health and 76 papers in Molecular Biology. Recurrent topics in Dan Douer's work include Acute Lymphoblastic Leukemia research (77 papers), Acute Myeloid Leukemia Research (72 papers) and Retinoids in leukemia and cellular processes (45 papers). Dan Douer is often cited by papers focused on Acute Lymphoblastic Leukemia research (77 papers), Acute Myeloid Leukemia Research (72 papers) and Retinoids in leukemia and cellular processes (45 papers). Dan Douer collaborates with scholars based in United States, Israel and Canada. Dan Douer's co-authors include Martin S. Tallman, H. Phillip Koeffler, Eric L. Chang, Joachim Yahalom, Richard L. Bakst, Jae H. Park, Hagop M. Kantarjian, Ibrahim Aldoss, David A. Scheinberg and H P Koeffler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Investigation.

In The Last Decade

Dan Douer

184 papers receiving 5.5k citations

Hit Papers

United States Multicenter... 2001 2026 2009 2017 2001 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dan Douer 3.0k 2.9k 1.6k 818 804 192 5.7k
Pau Montesinos 3.8k 1.3× 2.8k 0.9× 996 0.6× 1.1k 1.4× 242 0.3× 309 5.3k
Joseph Brandwein 2.7k 0.9× 1.8k 0.6× 1.2k 0.7× 1.8k 2.2× 646 0.8× 191 5.3k
Matt Kalaycio 3.3k 1.1× 1.4k 0.5× 931 0.6× 1.2k 1.5× 296 0.4× 291 5.1k
Ursula Creutzig 5.2k 1.7× 2.5k 0.9× 3.0k 1.8× 1.8k 2.2× 812 1.0× 217 7.6k
Giuseppe Avvisati 5.0k 1.7× 4.1k 1.4× 987 0.6× 1.5k 1.9× 131 0.2× 202 7.5k
R Ohno 4.1k 1.4× 2.2k 0.7× 1.3k 0.8× 1.2k 1.4× 127 0.2× 104 5.7k
John W. Adamson 5.5k 1.8× 1.3k 0.4× 389 0.2× 775 0.9× 597 0.7× 116 8.0k
Massimo Breccia 4.1k 1.4× 1.7k 0.6× 711 0.4× 942 1.2× 194 0.2× 403 5.6k
David D. Hurd 2.4k 0.8× 1.2k 0.4× 734 0.4× 1.6k 1.9× 179 0.2× 159 4.8k
Stéphane de Botton 4.1k 1.4× 3.0k 1.0× 997 0.6× 1.2k 1.5× 111 0.1× 201 6.2k

Countries citing papers authored by Dan Douer

Since Specialization
Citations

This map shows the geographic impact of Dan Douer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Douer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Douer more than expected).

Fields of papers citing papers by Dan Douer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Douer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Douer. The network helps show where Dan Douer may publish in the future.

Co-authorship network of co-authors of Dan Douer

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Douer. A scholar is included among the top collaborators of Dan Douer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Douer. Dan Douer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Douer, Dan, et al.. (2022). Asparaginase: How to Better Manage Toxicities in Adults. Current Oncology Reports. 25(1). 51–61. 3 indexed citations
3.
Nelson, Rebecca A., Ibrahim Aldoss, Vinod Pullarkat, et al.. (2021). Immunophenotype of acute lymphoblastic leukemia in minorities‐ analysis from the SEER database. Hematological Oncology. 40(1). 106–111. 3 indexed citations
6.
Aldoss, Ibrahim, et al.. (2018). The emerging story of acute lymphoblastic leukemia among the Latin American population – biological and clinical implications. Blood Reviews. 33. 98–105. 41 indexed citations
8.
Douer, Dan. (2016). A Woman With CD19-Positive, B-Cell ALL.. 14. 15. 2 indexed citations
9.
Ganzel, Chezi, Judith Manola, Dan Douer, et al.. (2016). Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008. Journal of Clinical Oncology. 34(29). 3544–3553. 85 indexed citations
10.
Park, Jae H., Baozhen Qiao, Katherine S. Panageas, et al.. (2011). Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. 118(5). 1248–1254. 279 indexed citations
11.
Baljević, Muhamed, Jae H. Park, Eytan M. Stein, et al.. (2011). Curing All Patients with Acute Promyelocytic Leukemia: Are We There Yet?. Hematology/Oncology Clinics of North America. 25(6). 1215–1233. 15 indexed citations
12.
Liu, Stephen V., et al.. (2011). Therapy-Related Acute Myeloid Leukemia following Treatment with Trabectedin for Ewing’s Sarcoma. Acta Haematologica. 126(2). 76–78.
13.
Gallaher, Timothy K., et al.. (2008). Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice. Journal of Translational Medicine. 6(1). 26–26. 13 indexed citations
14.
Douer, Dan, et al.. (2003). Induction of Complete Remission Using Single Agent Clofarabine in a Patient with Primary Refractory Acute Myeloblaste Leukemia. Leukemia & lymphoma. 44(12). 2135–2136. 1 indexed citations
15.
Douer, Dan. (2000). Transcription therapy for acute promyelocytic leukaemia. Expert Opinion on Investigational Drugs. 9(2). 329–346. 5 indexed citations
16.
Sagi‐Assif, Orit, Dan Douer, & Isaac P. Witz. (1999). Cytokine Network Imbalances in Plasmacytoma-Regressor Mice. Current topics in microbiology and immunology. 246. 395–401. 1 indexed citations
17.
Keung, Yi‐Kong, et al.. (1994). Comparative study of infections complications of different types of chronic central venous access devices. Cancer. 73(11). 2832–2837. 38 indexed citations
18.
Somekh, Eli, et al.. (1989). In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.. Journal of Pharmacology and Experimental Therapeutics. 248(1). 415–418. 53 indexed citations
19.
Witz, Isaac P., et al.. (1989). Effect in vivo of recombinant GM‐CSF on neutropenia and survival in mice treated by high‐dose melphalan. European Journal Of Haematology. 43(3). 240–244. 1 indexed citations
20.
Douer, Dan, et al.. (1978). Serum immunoglobulin levels in patients with Hodgkin's disease: relation to disease activity and clinical stage.. PubMed. 4(3). 209–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026